Central China New Life (HKSE:09983) Other Stockholders Equity: HK$249 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09983 Central China New Life Ltd HKSE:09983
66 GF Score
Price HK$0.29
GF Value HK$1.39
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Central China New Life Other Stockholders Equity?

Central China New Life HKSE:09983 -1.69% 66 Other Stockholders Equity is HK$249 Mil as of Dec. 2025. GuruFocus rates HKSE:09983 with a GF Score™ of 66/100 and a GF Value™ of HK$1.39 (Possible Value Trap). The stock has 6 warning signs investors should review.

Central China New Life's Other Stockholders Equity for the quarter that ended in Dec. 2025 was HK$249 Mil.

Central China New Life's quarterly Other Stockholders Equity declined from Dec. 2024 (HK$244 Mil) to Jun. 2025 (HK$243 Mil) but then increased from Jun. 2025 (HK$243 Mil) to Dec. 2025 (HK$249 Mil).

Central China New Life's annual Other Stockholders Equity increased from Dec. 2023 (HK$221 Mil) to Dec. 2024 (HK$244 Mil) and increased from Dec. 2024 (HK$244 Mil) to Dec. 2025 (HK$249 Mil).

Central China New Life Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Central China New Life's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central China New Life Other Stockholders Equity Chart

Central China New Life Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 80.54 169.43 220.55 243.86 249.29

Central China New Life Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 220.55 217.63 243.86 242.70 249.29
HKSE:09983
66GF Score
Central China New Life Ltd HKSE:09983
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central China New Life Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of HK$249 Mil mean?
Central China New Life (HKSE:09983) has a Other Stockholders Equity of HK$249 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Central China New Life and its competitors.
Is Central China New Life's Other Stockholders Equity too high?
Central China New Life's current Other Stockholders Equity is HK$249 Mil. Overall, Central China New Life has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Central China New Life's Other Stockholders Equity compare to CBRE and BEKE?
Central China New Life's Other Stockholders Equity of HK$249 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Real Estate company?
A good Other Stockholders Equity depends on the Real Estate industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Central China New Life and its competitors. Central China New Life's current Other Stockholders Equity is HK$249 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central China New Life stock overvalued right now?
Based on GuruFocus' analysis, Central China New Life (HKSE:09983) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.39, compared to a current price of HK$0.29 — trading 79.1% below its estimated fair value. The current Other Stockholders Equity is HK$249 Mil. Central China New Life's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Central China New Life (HKSE:09983), the current Other Stockholders Equity is HK$249 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Central China New Life (HKSE:09983) Overvalued in 2026?

Based on GuruFocus' analysis, Central China New Life stock appears to be undervalued. The current stock price of HK$0.29 is trading 79.1% below its estimated GF Value™ of HK$1.39. GuruFocus considers Central China New Life to be Possible Value Trap.

Key valuation signals for HKSE:09983:

  • Other Stockholders Equity: HK$249 Mil
  • GF Value™: HK$1.39 vs. price of HK$0.29 (79.1% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the HKSE:09983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Central China New Life Business Description

Address No. 19 Dirun Road, Room 411, 4th Floor, Building 2, Jianye Office Building, Zhengdong New District, Henan Province, Zhengzhou, CHN
Central China New Life Ltd is a property management company in central China with a geographical focus in Henan province. The revenue of the Group was generated from three main business lines: property management services; community value-added services; and value-added services to non-property owners. The company generates the majority of its revenue from property management services. The Group mainly operates its businesses in the PRC and earns substantially all of the revenue from customers in the PRC region.
66GF Score

Get the complete analysis for HKSE:09983

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.29
Price
HK$1.39
GF Value